Literature DB >> 15361396

Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome.

A Hartkamp1, R Geenen, M Bijl, A A Kruize, G L R Godaert, R H W M Derksen.   

Abstract

OBJECTIVE: To test whether serum levels of selected cytokines relate to different dimensions of fatigue in patients with primary Sjögren's syndrome (pSS).
METHODS: Sixty female patients with pSS filled out a questionnaire to assess multiple dimensions of fatigue. Scores were compared with values in a population based control group (n = 139). Levels of interleukin (IL)1beta, IL2, IL6, IL10, and tumour necrosis factor alpha were measured in serum with commercial sandwich ELISAs. The relationship between self reported dimensions of fatigue and these serum cytokine levels was determined.
RESULTS: Patients with pSS had high scores at all dimensions of fatigue (p<0.001): general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue. Fatigue levels were not related to serum cytokine levels. The incidental finding that reduced motivation was higher in patients with detectable serum levels of IL10 (p = 0.04) disappeared after correction for multiple testing.
CONCLUSION: Fatigue is prominent in patients with pSS and involves all dimensions of fatigue. The findings do not suggest a widespread effect of circulating cytokines on multiple aspects of fatigue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361396      PMCID: PMC1754758          DOI: 10.1136/ard.2003.011825

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Challenges in interpreting cytokine biomarkers in biobehavioral research: a breast cancer exemplar.

Authors:  Debra Lyon; Jeanne Walter; Cindy L Munro; Christine M Schubert; Nancy L McCain
Journal:  Biol Res Nurs       Date:  2011-01       Impact factor: 2.522

2.  Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.

Authors:  M N Pham; M I Hawa; C Pfleger; M Roden; G Schernthaner; P Pozzilli; R Buzzetti; W A Scherbaum; W Scherbaum; J Seissler; H Kolb; S Hunter; R D G Leslie; N C Schloot
Journal:  Diabetologia       Date:  2011-02-24       Impact factor: 10.122

3.  A five-year prospective study of fatigue in primary Sjögren's syndrome.

Authors:  Karstein Haldorsen; Ingvar Bjelland; Anne Isine Bolstad; Roland Jonsson; Johan Gorgas Brun
Journal:  Arthritis Res Ther       Date:  2011-10-13       Impact factor: 5.156

4.  Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations.

Authors:  Belgin Koçer; Mehmet Engin Tezcan; Hale Zeynep Batur; Şeminur Haznedaroğlu; Berna Göker; Ceyla İrkeç; Rümeysa Çetinkaya
Journal:  Brain Behav       Date:  2016-10-13       Impact factor: 2.708

Review 5.  An investigation into the prevalence of sleep disturbances in primary Sjögren's syndrome: a systematic review of the literature.

Authors:  Katie L Hackett; Zoe M Gotts; Jason Ellis; Vincent Deary; Tim Rapley; Wan-Fai Ng; Julia L Newton; Katherine H O Deane
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

6.  Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms.

Authors:  S Mechiel Korte; Rainer H Straub
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

7.  Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease.

Authors:  Waleed Hafiz; Rawad Nori; Ariana Bregasi; Babak Noamani; Dennisse Bonilla; Larissa Lisnevskaia; Earl Silverman; Arthur A M Bookman; Sindhu R Johnson; Carolina Landolt-Marticorena; Joan Wither
Journal:  Arthritis Res Ther       Date:  2019-11-04       Impact factor: 5.156

Review 8.  Managing fatigue in patients with primary Sjögren's syndrome: challenges and solutions.

Authors:  Samira Tatiyama Miyamoto; Dennis William Lendrem; Wan-Fai Ng; Katie Louise Hackett; Valéria Valim
Journal:  Open Access Rheumatol       Date:  2019-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.